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 13C NMR approaches have recently made it possible to study 
cerebral metabolism in more detail than with radioactive or nuclear 
medicine methods. Improvements in the technology now permit us to 
obtain in vivo, localized 13C NMR spectra from rodent or human brain 
with similar quality to those obtained earlier only under in vitro 
conditions, providing in this way a wealth of information on 
neurotransmitter recycling and cerebral bioenergetics in situ. 
Simultaneously, high-resolution 13C NMR approaches using cerebral 
extracts, brain slices or neural cell cultures are now yielding large 
amounts of detailed information on cerebral metabolic 
compartmentation and neuronal–glial interactions. These important 
advances are distributed in a plethora of publications in journals with 
very different profiles, making it difficult 
for the general scientific community to understand and integrate the 
abundant interdisciplinary information obtained in this field. This 
circumstance inspired me to prepare a special issue of NMR in 
Biomedicine on ‘13C NMR Studies of Cerebral Metabolism’, which 
aimed to provide from an integrative perspective, a comprehensive 
analysis of the ‘state of the art’ of in vivo and in vitro 13C NMR 
approaches and their contribution to our current understanding of 
cerebral function. 
Most neuroscientists would wish to start this issue by discussing 
whether 13C NMR entails sufficient advantages over more classical 
methodologies for investigating cerebral metabolism and if, as a 
consequence, 13C NMR methods have contributed any relevant 
information on cerebral function. To address this question properly it is 
important to remark here that the general concepts of cerebral 
metabolism were established much earlier than 13C NMR 
methodologies became available. Using conventional biochemical 
methods, it was possible to show that plasma glucose is the main 
substrate for the adult mammalian brain, providing both the energy and 
the carbon skeletons.  
 
 
Most previous methodologies for investigating cerebral glucose 
metabolism in vivo used 2-deoxyglucose, either labeled with 
radioactive isotopes such as 14C, or with positron emitting isotopes 
such as 18F.4,5 Both procedures are based in the fact that 2- 
deoxyglucose, a glucose analog transported to neural cells similarly to 
glucose, yields after intracellular phosphorylation the virtually 
unmetabolizable intermediate 2-deoxyglucose 6-phosphate. The 
corresponding 14C or 18F label accumulations detected by 
autoradiography or positron emission tomography (PET) make it 
possible to obtain spatially resolved measurements of glucose uptake 
or cerebral metabolic rates in different brain regions in vivo. 
More recently, functional magnetic resonance imaging (fMRI) has been 
able to determine indirectly the increases in cerebral activity through 
blood oxygenation level-dependent (BOLD) MRI contrast, a 
phenomenon thought to be caused by local changes in hemodynamics 
and in the oxygenation state of hemoglobin in those brain areas under 
motor or sensory activation. However, fundamental limitations of these 
traditional methodologies become apparent when considering the 
astroglial or neuronal location of glucose and energy metabolism, how 
these two different neural cell environments are functionally coupled 
and how this metabolic coupling supports global cerebral function and 
neurotransmission. Notably, autoradiography, PET or fMRI do not have 
the ability to determine the neuronal or glial origin of the increases in 
substrate and oxygen consumption supporting glutamatergic or 
GABAergic neurotransmissions. It is precisely in this respect where 
13C NMR approaches have been recently shown to become 
considerably powerful. In particular, in vivo and in vitro 13C NMR 
methods have provided novel information on many important aspects 
of modern neurochemistry, including the activity of the neuronal and 
glial tricarboxylic acid cycles and the operation of the intercellular 
glutamate–glutamine–GABA cycle in vivo, 8 on carbohydrate 
metabolism with emphasis on cerebral glycogen turnover, 9 on the 
biochemical basis of some neurological disorders in humans, on some 
novel cerebral metabolic pathways such as the pyruvate recycling 
system, on the exchange of metabolites between neurons and glial 
cells, on the subcellular compartmentation of neurotransmitter amino 
acids and many others. 
 
 
 
It should noted here that the admitted advantages of the 13C NMR 
approach do not imply that it is devoid of drawbacks. Indeed, 13C NMR 
is severely limited by its inherently low sensitivity, and its human 
applications remain at the academic level because of the considerable 
cost of the equipment and the 13C-enriched isotopes required. These 
adverse circumstances hamper the spatial localization of events 
occurring in small cerebral structures, preclude the resolution in time of 
fast metabolic processes and make it difficult to extend 13C NMR 
studies to the increasingly cost-conscious clinical scene. Despite these 
disadvantages, the continuous increases in field strength of modern 
spectrometers, the development of more sensitive forms of indirect 1H-
observed 13C NMR spectroscopy, the use of the faster timescale of 
13C detected hydrogen turnover, and the increasing demand for 13C 
isotopes and clinical high field magnets promise important 
improvements in spatial or temporal resolution, as well as in cost, of 
the 13C NMR examinations in the near future. 
The present issue of NMR in Biomedicine covers in several review 
articles the current status of in vivo and in vitro 13C NMR methods, 
providing in addition, a series of original papers addressing key 
aspects of modern neurochemistry. Review articles begin with a 
reflection on the application of 13C NMR to studies of cerebral 
metabolism (see Morris and Bachelard), followed by authoritative 
descriptions of the state of the art of in vivo (Gruetter et al. and de 
Graaf et al.) or in vitro 13C NMR (Zwingmann and Leibfritz), and 
illustrative applications in both rodent models of neurological diseases 
(Sonnewald and Kondziella) and clinical studies in humans (Lin et al.). 
The original papers address important and unresolved issues in 
cerebral biochemistry such as the use of LC Model to interpret 
quantitatively dynamic changes in 13C isotopomer populations from 
13C NMR spectra obtained in vivo (Henry et al.), the turnover and 
role of NAA in cerebral metabolism (Karelson et al.) or the mechanisms 
of metabolic coupling and substrate selection in neurons and 
astrocytes in normal and diseased brain (Serres et al. and García-
Espinosa et al.). To compile this issue I looked for the assistance of 
recognized specialists in the various a spects of cerebral 13C NMR. I 
am deeply indebted to the many friends and colleagues who accepted 
my invitation and devoted their time and effort to writing reviews and 
research articles. My gratitude is extended also to the Editorial Board 
of NMR in Biomedicine and John Wiley and Sons for their always 
enthusiastic support in the production of this issue. 
Finally, many important aspects of cerebral metabolism remain 
incompletely understood. These involve among others, the quantitative 
role of glial cells supporting, modulating or even contributing to 
cerebral activation and neurotransmission, the precise metabolic 
coupling mechanisms between neurons and glial cells and their 
corresponding energetics or the metabolic basis of most 
neurodegenerative and psychiatric disorders. I sincerely hope that 
readers of this volume will find in its pages sufficient impetus to fulfill 
these challenges and extend the use of 13C NMR to other areas of 
neurochemistry, contributing even more fundamental advances to 
cerebral metabolism than the ones presented here. 
 
